@Chat:the data for the last four month is very similar and flat to the data four month of beginning the year,which is not good ,but not deteriorated in essence.The major generic drug industry in US has been severely challenged.Teva's Q3 did not meet the standard,but Sp rose over40%,because of the good outlook.Our firm believe is to be optimistic about the future developments of MYX.So I think market is over sold.
@Chat:the data for the last four month is very similar and flat...
Add MYX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.37 |
Change
-0.010(0.23%) |
Mkt cap ! $371.7M | |||
| Open | High | Low | Value | Volume |
| $4.39 | $4.44 | $4.35 | $309.7K | 70.59K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 544 | $4.37 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.39 | 139 | 1 |
View Market Depth
| Last trade - 16.10pm 29/07/2024 (20 minute delay) ? |
| MYX (ASX) Chart |